Performance of the EndPAC risk score for pancreatic cancer in new onset diabetes patients with missing data – a database study in the British population
Pancreatology · 2025-12 · 25 (8) · 1434-1441
DOI: 10.1016/j.pan.2025.09.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2025-12. Verfasst von C Mellenthin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Hospital Fribourg, Switzerland; Arztpraxis am Bager, Schmitten, Switzerland; Basel Pharmacoepidemiology Unit, Division of Clin…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Diabetes Mellitus, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stiftung Krebsforschung Schweiz.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Hospital Fribourg, Switzerland; Arztpraxis am Bager, Schmitten, Switzerland; Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences,…
- Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Hospital Pharmacy, University Hospital Basel, Basel, Switz…
- Boston Collaborative Drug Surveillance Program, Lexington, MA, United States; Boston University School of Public Health, Boston, MA, United States.
- Department of Surgery, Hospital Fribourg, Switzerland; Department of of Medical and Surgical Specialties, Faculty of Science and Medicine, University of Fribourg, Switzerland.
- Department of of Medical and Surgical Specialties, Faculty of Science and Medicine, University of Fribourg, Switzerland; Faculty of Medicine, University of Basel, Basel, Switzerland.
Förderung
- Stiftung Krebsforschung Schweiz
Zitieren
APA
Mellenthin, C., Meier, C. R., Jick, S. S., Bühler, L. H., Adamina, M., & Schneider, C. (2025). Performance of the EndPAC risk score for pancreatic cancer in new onset diabetes patients with missing data – a database study in the British population. Pancreatology, 25(8), 1434-1441. https://doi.org/10.1016/j.pan.2025.09.017
Vancouver
Mellenthin C, Meier CR, Jick SS, Bühler LH, Adamina M, Schneider C. Performance of the EndPAC risk score for pancreatic cancer in new onset diabetes patients with missing data – a database study in the British population. Pancreatology. 2025;25(8):1434-1441. doi:10.1016/j.pan.2025.09.017
BibTeX
@article{Mellenthin2025,
author = {Mellenthin, C and Meier, C R and Jick, S S and Bühler, L H and Adamina, M and Schneider, C},
title = {Performance of the EndPAC risk score for pancreatic cancer in new onset diabetes patients with missing data – a database study in the British population},
journal = {Pancreatology},
year = {2025},
volume = {25},
number = {8},
pages = {1434--1441},
doi = {10.1016/j.pan.2025.09.017}
}
EUVIMED